Literature DB >> 1527091

Post-translational processing events in the secretion pathway of human protein C, a complex vitamin K-dependent antithrombotic factor.

D B McClure1, J D Walls, B W Grinnell.   

Abstract

Human protein C (HPC) undergoes several post-translational modifications, including gamma-carboxylation, N-linked glycosylation, and internal proteolytic processing. We have utilized a recombinant human kidney cell line (293) secreting correctly modified HPC (rHPC) to study the processing reactions for the modification of this complex protein. gamma-Carboxylation was shown to proceed via a vitamin K-dependent pathway and was required for both efficient secretion and anticoagulant activity. rHPC was rapidly secreted following the addition of vitamin K to depleted cells, and secretion was not inhibited by cyclohexamide indicating that non gamma-carboxylated rHPC accumulates as an intracellular releasable pool. However, in cells grown in the presence of vitamin K, the majority of intracellular rHPC was gamma-carboxylated, suggesting that this post-translational modification is not rate limiting for secretion under conditions optimal for vitamin K-dependent carboxylation. Nonglycosylated rHPC was found to be secreted inefficiently, and processing of the N-linked core in the endoplasmic reticulum, but not in the Golgi, was required for secretion. Further, the intracellular rHPC present in vitamin K-supplemented cells was core glycosylated, but not processed past the high mannose step. gamma-Carboxylation occurred after core glycosylation, indicating that this modification is not cotranslational. Further, glycosylation and gamma-carboxylation were not coupled and did not need to proceed sequentially. Proteolytic processing of the internal KR dipeptide was found to occur late in the secretion pathway, and the cleavage was calcium-dependent. The secretion rate of rHPC was also calcium-dependent but was independent of the calcium effect on internal KR dipeptide removal, indicating that cleavage is not required for efficient secretion. Our results define the sequence of processing events, the subcellular localization of the processing reactions, and the rate-limiting steps in the secretion pathway for this complex protein.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1527091

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  Modeling zymogen protein C.

Authors:  L Perera; C Foley; T A Darden; D Stafford; T Mather; C T Esmon; L G Pedersen
Journal:  Biophys J       Date:  2000-12       Impact factor: 4.033

2.  Heterogeneity in utilization of N-glycosylation sites Asn624 and Asn138 in human lactoferrin: a study with glycosylation-site mutants.

Authors:  P H van Berkel; H A van Veen; M E Geerts; H A de Boer; J H Nuijens
Journal:  Biochem J       Date:  1996-10-01       Impact factor: 3.857

3.  Intraovarian thrombin and activated protein C signaling system regulates steroidogenesis during the periovulatory period.

Authors:  Yuan Cheng; Kazuhiro Kawamura; Masashi Deguchi; Seido Takae; Sabine M Mulders; Aaron J W Hsueh
Journal:  Mol Endocrinol       Date:  2011-12-29

4.  Models of the serine protease domain of the human antithrombotic plasma factor activated protein C and its zymogen.

Authors:  C L Fisher; J S Greengard; J H Griffin
Journal:  Protein Sci       Date:  1994-04       Impact factor: 6.725

5.  Isolation and characterization of glycosylated neuropeptides.

Authors:  Yang Liu; Qinjingwen Cao; Lingjun Li
Journal:  Methods Enzymol       Date:  2019-08-12       Impact factor: 1.600

6.  Exon 2 skipping eliminates γ-glutamyl carboxylase activity, indicating a partial splicing defect in a patient with vitamin K clotting factor deficiency.

Authors:  Mark A Rishavy; Kevin W Hallgren; Haitao Zhang; Kurt W Runge; Kathleen L Berkner
Journal:  J Thromb Haemost       Date:  2019-06-07       Impact factor: 5.824

7.  Functional characterization of the protein C A267T mutation: evidence for impaired secretion due to defective intracellular transport.

Authors:  Lena Tjeldhorn; Nina Iversen; Kirsten Sandvig; Jonas Bergan; Per Morten Sandset; Grethe Skretting
Journal:  BMC Cell Biol       Date:  2010-09-06       Impact factor: 4.241

8.  N-glycosylation microheterogeneity and site occupancy of an Asn-X-Cys sequon in plasma-derived and recombinant protein C.

Authors:  Geun-Cheol Gil; William H Velander; Kevin E Van Cott
Journal:  Proteomics       Date:  2009-05       Impact factor: 3.984

9.  Regulation of human protein C gene expression by the mouse WAP promoter.

Authors:  R K Paleyanda; D W Zhang; L Hennighausen; R A McKnight; H Lubon
Journal:  Transgenic Res       Date:  1994-11       Impact factor: 2.788

10.  Coagulation Factor IX for Hemophilia B Therapy.

Authors:  N A Orlova; S V Kovnir; I I Vorobiev; A G Gabibov
Journal:  Acta Naturae       Date:  2012-04       Impact factor: 1.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.